MIRA Stock Summary and Trading Ideas (Mira Pharmaceuticals | NASDAQ:MIRA)

Mira Pharmaceuticals Inc is a clinical-stage pharmaceutical development company focused on developing novel oral small-molecule therapeutics for neurologic, neuropsychiatric, metabolic, and inflammatory disorders. The company's pipeline includes three product candidates: Ketamir-2, MIRA-55, and SKNY-1, three drug candidates designed to address unmet medical needs across neuropathic and inflammatory pain, central nervous system disorders, and metabolic and behavioral conditions. The company operates as a single operating and reportable segment.

Mira Pharmaceuticals trades on the NASDAQ stock market under the symbol MIRA.

As of September 29, 2026, MIRA stock price declined to $0.87 with 54,932 million shares trading.

MIRA has a beta of 0.72, meaning it tends to be less sensitive to market movements. MIRA has a correlation of 0.02 to the broad based SPY ETF.

MIRA has a market cap of $36.62 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, MIRA traded as high as $6.40 and as low as $.51.

The top ETF exchange traded funds that MIRA belongs to (by Net Assets): VTI, VXF, IWC.

MIRA has underperformed the market in the last year with a return of -34.0%, while the SPY ETF gained +16.6%. In the last 3 month period, MIRA fell short of the market, returning -13.7%, while SPY returned +5.1%. However, in the most recent 2 weeks MIRA has outperformed the stock market by returning +15.8%, while SPY returned +0.7%.

MIRA support price is $.84 and resistance is $.96 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MIRA shares will trade within this expected range on the day.